KalVista Pharmaceuticals, Inc.KALVNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.28
Net Income/Share$-3.90
Operating CF/Share$-2.97
Free CF/Share$-2.98
Cash/Share$5.74
Book Value/Share$0.32
Tangible Book/Share$0.32
Equity/Share$0.32
Interest Debt/Share$3.04
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$816.83M
Enterprise Value$722.92M
P/E Ratio-4.14P/S Ratio54.03P/OCF Ratio-5.43
P/FCF Ratio-5.10
P/B Ratio51.22P/TB Ratio51.22
EV/Sales47.82EV/EBITDA-3.76
Graham Valuation
Graham Number--
Graham Net-Net$-0.15
Profitability
Earnings Yield-24.15%FCF Yield-19.63%ROE-282.01%ROIC-68.52%Return on Tangible Assets-61.87%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.06%
CapEx/Revenue0.60%
CapEx/Depreciation0.09
SBC/Revenue36.60%
SG&A/Revenue1062.87%
R&D/Revenue368.04%
Liquidity & Solvency
Debt/Equity8.80Debt/Assets0.44Debt/Market Cap0.18
Net Debt/EBITDA0.49
Current Ratio7.22Interest Coverage-14.44xIncome Quality0.76Efficiency
Days Sales Outstanding172 days
Days Payables Outstanding166 days
Days Inventory9 days
Receivables Turnover2.12x
Payables Turnover2.19x
Inventory Turnover38.67x
Capital Structure
Tangible Assets$17.00M
Working Capital$280.16M
Invested Capital$292.44M
Intangibles/Assets0.00%